Tower Research Capital LLC (Trc) Outlook Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.22 - $0.66 $5,203 - $15,609	-23,651 Reduced 50.74%	22,957 $8,000
Q3 2023 Nov 14, 2023	BUY	$0.2 - $1.78 $8,397 - $74,740	41,989 Added 909.05%	46,608 $10,000
Q2 2023 Aug 14, 2023	SELL	$1.02 - $1.89 $19,305 - $35,772	-18,927 Reduced 80.38%	4,619 $8,000
Q1 2023 May 09, 2023	BUY	$1.0 - $1.35 $15,928 - $21,502	15,928 Added 209.08%	23,546 $26,000
Q4 2022 Feb 10, 2023	SELL	$0.87 - $1.33 $29,999 - $45,861	-34,482 Reduced 81.9%	7,618 $8,000
Q3 2022 Nov 10, 2022	BUY	$1.02 - $1.26 $26,484 - $32,715	25,965 Added 160.92%	42,100 $51,000
Q2 2022 Aug 15, 2022	SELL	$0.91 - $2.01 $56,704 - $125,249	-62,313 Reduced 79.43%	16,135 $16,000
Q1 2022 May 12, 2022	BUY	$1.22 - $2.03 $66,487 - $110,630	54,498 Added 227.55%	78,448 $139,000
Q4 2021 Feb 14, 2022	BUY	$1.27 - $2.23 $5,933 - $10,418	4,672 Added 24.23%	23,950 $33,000
Q3 2021 Nov 15, 2021	BUY	$2.12 - $2.76 $37,072 - $48,264	17,487 Added 976.38%	19,278 $42,000
Q2 2021 Aug 16, 2021	SELL	$1.78 - $2.76 $40,206 - $62,342	-22,588 Reduced 92.65%	1,791 $4,000
Q1 2021 May 17, 2021	BUY	$0.94 - $3.31 $16,557 - $58,302	17,614 Added 260.37%	24,379 $55,000
Q4 2020 Feb 16, 2021	BUY	$0.7 - $1.58 $4,735 - $10,688	6,765 New	6,765 $9,000

31.5K

Ticker OTLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,144,992
Market Cap $1.21B
Description
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.